http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010115268-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 |
| filingDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010115268-A |
| titleOfInvention | SOLUBLE DOSED FORMS CONTAINING CEPHEMA DERIVATIVES ACCEPTABLE FOR Parenteral Administration |
| abstract | 1. A dosage form containing ceftaroline or a pharmaceutically acceptable salt and / or solvate thereof and / or a prodrug thereof and a solubilizing agent, wherein the molarity of the solubilizing agent in the aqueous solution of the dosage form is greater than about 0.1 M.! 2. The dosage form according to claim 1, where the molarity of the solubilizing agent is greater than about 0.5 M.! 3. The dosage form according to claim 1, where the molarity of the solubilizing agent is greater than about 1.0 M.! 4. The dosage form according to claim 1, containing ceftaroline fosamil, where ceftaroline fosamil is ceftaroline fosamyl monoacetate monohydrate (USAN) or ceftaroline fosamyl anhydrous, acetate-free (INN). ! 5. The dosage form according to claim 4, where ceftaroline fosamil has a solubility in water greater than about 40 mg / ml. ! 6. The dosage form according to claim 4, where ceftaroline fosamil has a solubility in water greater than about 100 mg / ml. ! 7. The dosage form according to claim 4, where ceftaroline fosamil has a solubility in water greater than about 200 mg / ml. ! 8. The dosage form according to claim 1, where the solubilizing agent is selected from carboxylic acids and amino acids. ! 9. The dosage form according to claim 1, where the solubilizing agent is selected from the group consisting of formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid acid, stearic acid, acrylic acid, docosahexaenoic acid, eicosapentaenoic acid, pyruvic acid, benzoic acid |
| priorityDate | 2007-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.